Trabalhos completos publicados em periódicos

Trabalhos completos publicados em periódicos

Seleção dos mais relevantes desde 2001

Lima ACM, Getz J, do Amaral GB, Loth G, Funke VAM, Nabhan SK, Petterle RR, de Marco R, Gerbase-DeLima M, Pereira NF, Bonfim C, Pasquini R. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation. Transplant Cell Ther. 2023 Aug;29(8):493.e1-493.e10. doi: 10.1016/j.jtct.2023.05.014.
de Marco R, Requião-Moura LR, Raimundo TRF, Mourão TB, Rampim GF, Medina-Pestana JO, Tedesco-Silva H, Gerbase-DeLima M. HLA-DPB1 molecular mismatches are risk factors for acute rejection and low 5-year graft function in first kidney transplants. HLA. 2023 Mar;101(3):228-238. doi: 10.1111/tan.14911.
Lima ACM, Bonfim C, Getz J, do Amaral GB, Petterle RR, Loth G, Nabhan SK, de Marco R, Gerbase-DeLima M, Pereira NF, Pasquini R. Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders. Transplant Cell Ther. 2022 Oct;28(10):698.e1-698.e11. doi: 10.1016/j.jtct.2022.07.019.
Mine KL, de Marco R, Raimundo TRF, Ernesto JV, Medina-Pestana JO, Tedesco-Silva H, Gerbase-DeLima M. High soluble HLA-DQB2 levels in posttransplant serum are associated with kidney graft dysfunction. Int J Immunogenet. 2022 Apr;49(2):63-69. doi: 10.1111/iji.12569.
Nunes Ficher K, Dreige Y, Gessolo Lins PR, Nicolau Ferreira A, Toniato de Rezende Freschi J, Linhares K, Stopa Martins S, Custodio L, Cristelli M, Viana L, Wagner Santos D, de Marco R, Gerbase-DeLima M, Proença H, Aguiar W, Nakamura M, Rosso Felipe C, Medina Pestana J, Tedesco Silva H Jr. Long-term Efficacy and Safety of Everolimus Versus Mycophenolate in Kidney Transplant Recipients Receiving Tacrolimus. Transplantation. 2022 Feb 1;106(2):381-390. doi: 10.1097/TP.0000000000003714.
Linhares K, Taddeo JB, Cristelli MP, Proença H, Ficher KN, de Marco R, Gerbase-DeLima M, Medina-Pestana J, Tedesco-Silva H. The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation. PLoS One. 2021 May 12;16(5):e0251384. doi: 10.1371/journal.pone.0251384.
De Marco R, Faria TC, Mine KL, Cristelli M, Medina-Pestana JO, Tedesco-Silva H, Gerbase-DeLima M. HLA-A homozygosis is associated with susceptibility to COVID-19. HLA. 2021;98:122-131. doi: 10.1111/tan.14349.
Iacontini EGR, Rampim GF, Terapin CF, de Lima MG, de Freitas Dutra V. Identification of the novel HLA-a*68:250 allele in a volunteer bone marrow donor from Sao Paulo, Brazil. HLA. 2021; 97:541-543. doi: 10.1111/tan.14253.
Gerbase-Delima M,de Marco R, Monteiro F,Tedesco-Silva H, Medina-Pestana JO,Mine KL.Impact of combinations of donorand recipient ages and other factors on kidney graft outcomes. Front lmmunol. 2020;22;11:954.doi: 0.3389/ fimmu.2020.00954.
GrenziPC, Campos EF,Tedesco-Silva H Jr,Felipe CR, Soares MF, Medina-Pestana J,Hansen HP, Gerbase-Delima M. Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients. Hum lmmunol. 2018;79:550-557. doi: 10.1016/j.humimm.2018.04.002.
Mine KL, Tedesco-Silva H, Mourao TB,Campos EF,Salzedas LA, Aguiar B,Felipe CR, Medina-Pestana JO, Gerbase-Delima M. Heightened expression of HLA-DQBl and HLA-DQB2 in pre-implantation biopsies predicts poorlate kidney graft function. Hum lmmunol. 2018;79:594-60 1.doi: 10.1016/j.humimm.2018.05.002.
Rampim GF,Araujo AS, Mourao TB, Furuyama TN,Gerbase-Delima M. HLA-B'15:04:04, a novelHLA allele identified duringproficiency testingin Brazil. HLA. 2016;88:200-1. doi:10.1111/tan.12866.
Mourao TB,Mine KL, Campos EF,Medina-Pestana JO, Tedesco-Silva H,Gerbase-DeLima M. Predicting delayed kidney graft function with gene expression in preimplantation biopsies and first-day posttransplant blood.Hum lmmunol. 2016;77:353-7.doi: 10.1016/j.humimm.2016.02.002.
GrenziPC, Campos EF,Silva HT Jr,Felipe CR, Franco MF, Soares MF,Medina-Pestana JO, Gerbase- Delima M. Post-transplant soluble CD30levels are associated with early subclinicalrejection in kidney transplantation. Transpl lmmunol.2015;32:61-5. doi:10.1016/j.trim.2015.02.004.
Echeverria VF,Rampim GF,Gerbase-Delima M. The HLA-A 02:481allele was identified in unrelated Brazilians sharing HLA-B. 15:17,C-07:01P,DRBl*13:02 and DQB •o6:04.Tissue Antigens. 20 14; 84:577-8. doi: 10.1111/tan.12468.
Goncalves-Primo A, Mourao TB, Andrade-Oliveira V, Campos EF,Medina-Pestana JO,Tedesco-Silva H, Gerbase-Delima M. Investigation of apoptosis-related gene expression levels in preimplantation biopsies as predictors of delayed kidney graft function. Transplantation. 2014;97:1260-5. doi: 10.1097/01.TP.0000442579.12285.e8
GrenziPC, Campos EF,Tedesco-S ilva H, Felipe CR, Franco MF,Soares MF,Medina-Pestana JO, Gerbase-Delima M.Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy.Transpl lmmunol. 2013;29:34-8. doi:10.1016/j.trim.2013.07.003.
GrenziPC, de Marco R,Silva RZ, Campos EF,Gerbase-Delima M.Antibodies against denatured HLA class II molecules detected in Luminex-single antigen assay. Hurn lmmunol. 2013;74:1300-3. doi: 10.1016/j.humimm.20 13.06.035.
Susa! C, Roelen DL, Fischer G, Campos EF,Gerbase-Delima M, Honger G, Schaub S, Lachmann N, Martorell J, Claas F.Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients.Tissue Antigens. 2013;82:83 92. doi: 10.1111/tan.12137.
Mine KL,Shulzhenko N,Yambartsev A, Rochman M, Sanson GF,Lando M,Varma S, Skinner J, Volfovsky N, Deng T,Brenna SM, Carvalho CR,Ribalta JC, Bustin M, Matzinger P,Silva ID,Lyng H,Gerbase-Delima M, Morgun A.Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun. 2013; 4:1806. doi: 10.1038/ncomms2693.
Andrade-Oliveira V, Campos EF,Goncalves-Primo A, GrenziPC, Medina-Pestana JO, Tedesco-Silva H, Gerbase-Delima M.TLR4 mRNAlevels as tools to estimate risk for early posttransplantat ion kidney graft dysfunction. Transplantation.2012;94:589-95.DOI:10.1097/TP.Ob013e3 1825db680.
Cangussu LO, Teixeira R,Campos EF,Rampim GF,Mingoti SA, Martins-Filho OA, Gerbase-Delima M. HLA class IIalleles and chronic hepatitis C virus infection. Scand J lmmunol. 2011;74:282-7.doi: 10.ll /j.1365-3083.2011.02568.x.
Veiga TR, Rampim GF,Gerbase-Delima M. Identification of a novelHLA-B*52 allele in a Brazilian individual: B'52:21. Tissue Antigens. 2011;77:342 3.doi:10. ll /j .l:J.99 0039.2011.01640.x.
Veiga TR, Rampim GF, de Lima MG. Identification of two novel HLA-Balleles inthe Brazilian population: B.4509 and B.5212. Tissue Antigens. 2010;76:153-4. doi: O.ll l/j.1399-0039.2010.01487.x.
Thakkinstian A, Dmitrienko S, Gerbase-Delima M,McDaniel DO,Inigo P,Chow KM, McEvoy M,lngsathit A, Trevillian P,Barber WH,Attia J. Association between cytokine gene polymorphisms and outcomes in renal transplantation:a meta-analysis of individualpatient data. Nephrol DialTransplant. 2008;23:3017-23.doi: 10.1093/ndt/gfnl85.
Campos EF,Tedesco-Silva H,Machado PG, Franco M, Medina-Pestana JO, Gerbase-Delima M. Post-transplant anti-HLA class IIantibodies as risk factor for late kidney allograft failure.Am J Transplant. 2006;6:2316-20. doi: 10.ll l/j.1600-6143.2006.01503.x.
Gerbase-Delima M,Campos EF,Tedesco-Silva H, Machado PG,Franco M,Medina-Pestana JO. Anti-HLA class IIantibodies and chronic allograft nephropathy. ClinTranspl. 2006:201-5. PMID: 18365378
Morgun A, Shulzhenko N,Perez-Diez A, Diniz RV,Sanson GF,Almeida DR, Matzinger P,Gerbase-DeLima M. Molecular profiling improves diagnoses of rejection and infection in transplanted organs.Circ Res. 2006;98:e74-83. doi:10.1161/0l.res.0000228714.15691.8a.
Perez EC, Shulzhenko N, Morgun A, Diniz RV,Almeida DR, Musatti CC, Gerbase-DeLima M. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardialbiopsies of human cardiac allografts. Hum lmmunol. 2006;67:22-6.doi: 10.1016/j.humimm.2006.02.037.
Kayser C, Alvarenga MC, Neves AS, Gerbase-De Lima M,Andrade LE. Severe ankylosing spondylitis and diffuse systemic sclerosis:case report of a genetic trap. Scand J Rheumatol. 2005;34:145-7. doi: 10.1080/03009740510026346.
Morgun A, Shulzhenko N, Socorro-Silva A, Diniz RV,Almeida DR, Gerbase-Delima M.T cell receptor excision circles (TRECs) in relation to acute cardiac allograft rejection.J Clin lmmunol. 2004;24:612-6. doi: 10.1007/sl0875-004-6246- l.
Witt CS, Goodridge J, Gerbase-Delima MG, Daher S, Christia nsen FT.MaternalKIR repertoireis not associated with recurrent spontaneous abortion. Hum Reprod.2004;19:2653-7.doi: 10.1093/humrep/deh483.
Morgun A, Shulzhenko N, Unterkircher CS, Diniz RV,Pereira AB,Silva MS, Nishida SK,Almeida DR, Carvalho AC, Franco M, Souza MM, Gerbase-Delima M. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome. J Heart Lung Transplant. 2004;23:204-9. doi: 10.1016/S 1053-2498( 03)00114-1.
Borducchi OM, Gerbase-Delima M, Morgun A, Shulzhenko N, Pombo-de-Oliveira MS,Kerbauy J,Rodrigues de Oliveira JS.Human leucocyte antigen and human T-celllymphotropic virus type 1associated diseases in Brazil. Br J Haematol. 2003;123:954-5. doi: 10.1046/j.1365-2141.2003.04711.x.
Morgun A, Shulzhenko N, Rampim GF,Medina JO, Machado PG, Diniz RV,Almeida DR, Gerbase-Delima M. lnterleukin-2 gene polymorphism is associated with rena1Ibut not cardiac transplant outcome.Transplant Proc. 2003;35:1344-5. doi:10.1016/s004 1-1345(03)00366-x.
Morgun A, Shulzhenko N, Rampim GF, Chinellato AP,Diniz RV, Almeida DR, Souza MM, Franco M, Gerbase-Delima M. Blood and intragraft CD27 gene expression incardiac transplant recipients.Clin lmmunol. 2003;107:60-4. doi: 10.1016/sl521-6616(02)00047-5.
TorrecilhasAC, Medina JO, Panajotopoulos N, Moura LA, Gerbase-Delima M.Detection and clinical significance of lymphocytotoxic antibodies following renaltransplantation. Transplant Proc. 2002;34:482-3. doi: 10.1016/s0041-1345(02)02603-9.
Shulzhenko N, Morgun A,Chinellato AP,Rampim GF,Diniz RV, Almeida DR, Gerbase-Delima M. CD27 but not CD70 and 4- BB intragraft gene expression isa risk factor for acute cardiac allograft rejection in humans. Transplant Proc. 2002;34:474-5. doi: 10.1016/s0041-1345(02)02600-3.
Morgun A, Shulzhenko N, Silva ID, Rampim GF,Chinellato A P,Borra RC, Gerbase-Delima M. Differentially expressed genes in cardiac transplant biopsies and in mixed lymphocyte culture.Transplant Proc. 2002;34:471-3. doi: 10.1016/s0041-l345(02)02599-x.
Shulzhenko N, Morgun A, Zheng XX, Diniz RV,Almeida DR, Ma N,Strom TB, Gerbase-Delima M. lntragraft activation of genes encoding cytotoxic Tlymphocyte effector molecules precedes the histologicalevidence of rejection in human cardiac transplantation. Transplantation. 2001;72:1705-8. doi: 10.1097/00007890-200111270-00025.
Shulzhenko N, Morgun A, Franco M, Souza MM,Almeida DR,Diniz RV,Carvalho AC, Pacheco-Silva A, Gerbase-Delima M. Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts:correlation with acute rejection. Braz J Med Biol Res. 2001;34:779-84. doi: 10.1590/s0100-879x2001000600013.
Shulzhenko N, Morgun A, Rampim GF,Franco M,Almeida DR, Diniz RV,CarvalhoAC,Gerbase-Delima M. Monitoringof intragraft and peripheralblood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans. Hum lmmunol. 2001;62:342-7. doi: 10.1016/s0198-8859(01)00211-7.
Morgun A, Shulzhenko N, Diniz RV,Almeida DR, Carvalho AC, Gerbase-De ima M. Cytokine and TIRC7 mRNA expression duringacute rejection in cardiac allograft recipients. Transplant Proc. 2001;33:1610-1.doi: 10.1o16/s0041-134S(00)02613-0.